Syndromes cliniques de SLA au cours des gammapathies: aspects cliniques, electrophysiologiques et histoimmunologiques

[1]  M. Gurney,et al.  Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. , 1984, The New England journal of medicine.

[2]  R. Kyle.  'Benign' monoclonal gammopathy. A misnomer? , 1984, JAMA.

[3]  F. Regli,et al.  Manifestations neurologiques des gammapathies monoclonales. , 1984 .

[4]  A. Hays,et al.  Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study. , 1983, Annals of neurology.

[5]  C. Melmed,et al.  Amyotrophic lateral sclerosis and paraproteinemia , 1982, Neurology.

[6]  R. Lovelace,et al.  Macroglobulinemia with peripheral neuropathy simulating motor neuron disease , 1982, Annals of neurology.

[7]  S. Hickman.  Benign monoclonal gammopathy. , 1982, Archives of internal medicine.

[8]  P. Pinelli,et al.  Neuromuscular diseases associated with benign monoclonal gammopathy , 1982, Acta neurologica Scandinavica.

[9]  F. Roisen,et al.  Neuron specific in vitro cytotoxicity of sera from patients with amyotrophic lateral sclerosis , 1982, Muscle & nerve.

[10]  E. Richardson,et al.  Case 31-1977 , 1977 .

[11]  Y. Olsson,et al.  MACROGLOBULINEMIA WALDENSTRÖM AND MOTOR NEURON SYNDROME , 1977, Acta neurologica Scandinavica.

[12]  G. Chazot,et al.  [Neurological manifestations in monoclonal gammapathies. Pure neurological manifestations. Immunofluorescence study]. , 1976, Revue neurologique.

[13]  B. Brownell,et al.  The central nervous system in motor neurone disease , 1970, Journal of neurology, neurosurgery, and psychiatry.

[14]  H. Peters,et al.  Spinal muscular atrophy secondary to macroglobulinemia: Reversal of symptoms with chlorambucil therapy , 1968, Neurology.

[15]  U. Axelsson,et al.  Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. , 2009, Acta medica Scandinavica.